These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21760540)

  • 1. Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid β protein antibody-coated nanoparticles.
    Poduslo JF; Hultman KL; Curran GL; Preboske GM; Chamberlain R; Marjańska M; Garwood M; Jack CR; Wengenack TM
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):653-61. PubMed ID: 21760540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging.
    Ramakrishnan M; Wengenack TM; Kandimalla KK; Curran GL; Gilles EJ; Ramirez-Alvarado M; Lin J; Garwood M; Jack CR; Poduslo JF
    Pharm Res; 2008 Aug; 25(8):1861-72. PubMed ID: 18443900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.
    Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ
    Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
    Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy.
    Beckmann N; Gérard C; Abramowski D; Cannet C; Staufenbiel M
    J Neurosci; 2011 Jan; 31(3):1023-31. PubMed ID: 21248127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody aβ1-40 in a transgenic mouse model.
    Kim JH; Ha TL; Im GH; Yang J; Seo SW; Lee IS; Lee JH
    Neuroreport; 2013 Jan; 24(1):16-21. PubMed ID: 23168564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.
    Bacskai BJ; Kajdasz ST; McLellan ME; Games D; Seubert P; Schenk D; Hyman BT
    J Neurosci; 2002 Sep; 22(18):7873-8. PubMed ID: 12223540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice.
    McGowan E; Pickford F; Kim J; Onstead L; Eriksen J; Yu C; Skipper L; Murphy MP; Beard J; Das P; Jansen K; DeLucia M; Lin WL; Dolios G; Wang R; Eckman CB; Dickson DW; Hutton M; Hardy J; Golde T
    Neuron; 2005 Jul; 47(2):191-199. PubMed ID: 16039562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
    Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
    Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
    Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Li J; Wang J; Hoang DM; Sun Y; Xu H; Tsui W; Li Y; Boutajangout A; Wang A; de Leon M; Wisniewski T
    PLoS One; 2013; 8(2):e57097. PubMed ID: 23468919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques.
    Kim JH; Ha TL; Im GH; Yang J; Seo SW; Chung JJ; Chae SY; Lee IS; Lee JH
    Neuroreport; 2014 Mar; 25(4):211-8. PubMed ID: 24518227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.
    Adolfsson O; Pihlgren M; Toni N; Varisco Y; Buccarello AL; Antoniello K; Lohmann S; Piorkowska K; Gafner V; Atwal JK; Maloney J; Chen M; Gogineni A; Weimer RM; Mortensen DL; Friesenhahn M; Ho C; Paul R; Pfeifer A; Muhs A; Watts RJ
    J Neurosci; 2012 Jul; 32(28):9677-89. PubMed ID: 22787053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
    Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
    Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.
    Sillerud LO; Solberg NO; Chamberlain R; Orlando RA; Heidrich JE; Brown DC; Brady CI; Vander Jagt TA; Garwood M; Vander Jagt DL
    J Alzheimers Dis; 2013; 34(2):349-65. PubMed ID: 23229079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.